Drug intelligence / Profile preview

micronutrients + docosahexaenoic acid

Development stage
Preclinical
Lead developer
Richen Nutritional Technology
Modality
Small Molecules
Administration
Oral
01

Overview

A combination dietary supplement containing a blend of **micronutrients** (11 vitamins and 6 minerals) and **docosahexaenoic acid (DHA)**, an omega-3 polyunsaturated fatty acid. The supplement is formulated to support cognitive function and healthy aging, designed specifically for populations at risk of nutritional deficiency, such as older adults. **Mechanisms of action** are attributed to the synergistic effects of micronutrient repletion (providing essential cofactors for cellular and neurological functions) and DHA, which is critical for neuronal membrane structure and function, as well as anti-inflammatory and antioxidant effects. The formulation is administered orally and often includes other ingredients such as phosphatidylserine. Current evidence suggests benefit in models of cognitive decline through enhancement of antioxidant defenses, reduction of neuroinflammation, and upregulation of neurotrophic factors[1][3].

Other names
micronutrients and docosahexaenoic acidmicronutrients plus DHA
02

Targets

FFAR1 (Free fatty acid receptor 1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on micronutrients + docosahexaenoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on micronutrients + docosahexaenoic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call